CRMD Q4 2017 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$92,526-24.0% YoY

Gross Profit

$29,21531.6% margin

Operating Income

-$10M-11100.2% margin

Net Income

-$10M-11143.4% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

+51.5%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$394,860

Balance Sheet

Total Assets

$13M

Total Liabilities

$6M

Stockholders' Equity

-$152M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92,526	$121,715	-24.0%
Gross Profit	$29,215	$36,384	-19.7%
Operating Income	-$10M	-$6M	-59.7%
Net Income	-$10M	-$6M	-61.1%